BiotechTube
Home/Inhalon Biopharma/Thomas Moench, MD
TM

Thomas Moench, MD

Vice President, Clinical

Inhalon Biopharma

Therapeutic Areas

Infectious DiseaseRespiratory

Inhalon Biopharma Pipeline

DrugIndicationPhase
IN-006COVID-19 (SARS-CoV-2)Phase 1b
IN-002Respiratory Syncytial Virus (RSV)Pre-IND
IN-007COVID-19 (SARS-CoV-2)Preclinical

Leadership Team at Inhalon Biopharma

JW
John Whelan
President, Chief Executive Officer and Director
SL
Sam Lai, PhD
Founder, Chief Scientific Officer and Director
View full Inhalon Biopharma profile